Evaluation of Glucose Management Software in Critically Ill Patients with Hyperglycemic Crises
Objective
This retrospective review examines the safety and effectiveness of a computerized glucose management system (EndoTool) for critically ill diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic states (HHS) patients.
Setting
1,041-bed non-profit tertiary care and academic medical center.
Results
- With an initial blood glucose >300 mg/dL, mean rate of blood glucose reduction was 87 mg/dL/hour, with 84% of patients achieving a rate of at least 50 mg/dL/hour.
- Incidence of severe hypoglycemia <40 mg/dL was 0.17% of blood glucose measurements and incidence of hypoglycemia <60 mg/dL was 0.79% of blood glucose measurements.
Conclusions
Management of continuous intravenous insulin infusion utilizing a computerized glucose management system (EndoTool) is both safe and effective at lowering blood glucose in DKA and HHS patients, with very minimal risk of hypoglycemia.
Authors
Maresa Glass, PharmD, BCPS; Kevin Ferguson, PharmD, BCPS; Mark Rumbak, MD.
Source
Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 42, Issue 12, pA1441.
Year
2014
Tags
- Cost Savings
- Healthcare-Associated Infections
- Hospital-Acquired Conditions
- Hyperglycemia Reduction
- Hypoglycemia Reduction
- Length of Stay
- Surgical Site Infections
- Glucose Variability
- Mean Glucose Improvement
- Target Goal Attainment
- Time in Range
- Time on IV Insulin
- Time to Target
- Burn Injury
- Cardiac Surgery
- DKA/HHS Management
- Emergency Department
- Induced Hypothermia
- Intra-op Glucose Management
- Obstetrics/Labor & Delivery
- Pediatrics
- Residual Insulin Adjustment
- BG Check Compliance
- BG Test Reduction
- Nursing Satisfaction
- Protocol Adherence
- Provider Satisfaction
- Workflow Improvements